Alicia Allen, PhD, MPH, began working in clinical research on substance use disorders in 2001 as an undergraduate student. This experience prompted her to obtain her masters in community health education, graduate certification in addiction studies and doctorate in social and behavioral epidemiology, all from the University of Minnesota. She also completed a fellowship at the Centers for Disease Control and Prevention in the area of prenatal smoking. As a behavioral epidemiologist, she is particularly interested in research study design and evaluating causality. She has conducted randomized clinical trials, controlled cross-over trials, and cross-sectional online surveys, as well as analyzed data from large epidemiological datasets. Dr. Allen's current research focuses on topics that occur in the intersection between substance misuse (e.g., nicotine/tobacco, cannabis, opioids) and women's health (e.g., pregnancy, postpartum, hormonal contraceptive use). Alicia has received funding from the National Institutes of Health, ClearWay Minnesota, and University of Arizona. She has published over 45 peer-reviewed manuscripts to-date, primarily with Addictive Behaviors, Nicotine and Tobacco Research, Addiction, and Journal of Addiction Medicine. She is an associate editor with Nicotine Tobacco Research (NTR), the clinical director with Society for Research on Nicotine Tobacco University (SRNT-U), and co-director of the Resident Scholarly Project Program (RSPP). In 2020, Dr. Allen received the prestigious National Institutes of Health’ New Innovator Award to explore how postpartum hormones influence relapse to opioids.
